10/09/2026
*Centre for Omic Sciences Peshawar Joins Forces with Broad Institute of MIT and Harvard in Genomics Consortium*
In a significant stride towards advancing genomic research, Dr. Muhammad llyas, Principal investigator of the genome project (NRPU-17341), has inked a collaboration agreement with the prestigious Broad Institute of MIT and Harvard. This partnership heralds a new chapter in the exploration of genetic variations and their implications for rare and common diseases in Khyber Pakhtunkhwa.
"l am thrilled to embark on this collaborative journey with the Broad Institute, a powerhouse of innovation and excellence in genomics research," expressed Dr llyas. "Together, we aim to delve deeper into the genetic landscape, uncovering novel insights that could pave the way for transformative advancements in healthcare."
The collaboration, however, extends beyond individual efforts, as it is part of the Genetic Diseases Consortium, a collective initiative aimed at unraveling the genetic underpinnings of various diseases. This collaborative approach underscores the significance of pooling resources and expertise to tackle complex scientific challenges on a global scale.
Reflecting on this landmark collaboration, Prof. Dr. Ali Muhammad, Vice Chancellor of Islamia College Peshawar, lauded Dr. llyas' initiative in joining forces with a renowned institution like the Broad Institute. "Dr. Muhammad Ilyas' collaboration with the Broad Institute marks a significant milestone in the journey of Pakistani scientists towards global recognition in genomic research," remarked Prof. Dr. Ali Muhammad
He also emphasized the importance of nurturing a conducive environment for scientific research and collaboration within Pakistan. "As a nation, it is imperative that we continue to support and invest in our scientific community, providing them with the resources and opportunities needed to thrive in their endeavors," concluded Prof. Dr. Ali Muhammad.
The partnership is poised to catalyze groundbreaking discoveries in the field of genetics, with a focus on identifying ethnic and tribal-specific mutations that hold the key to understanding both rare and common diseases. Through collaborative research projects and shared resources, Dr llyas and the Broad Institute seek to accelerate the pace of genomic discoveries and translate findings into tangible benefits for patients worldwide.